Altered nasal and oral microbiomes define pediatric sickle cell disease.
mSphere (2025)
Advancing Sickle Cell Disease Research and Treatment
The Sheehan Lab is dedicated to developing and improving therapies for individuals living with sickle cell disease. Our multifaceted approach combines genomics, clinical research, and innovative biomarker development to better understand and treat this complex disease.
Evaluating and improving gene therapy approaches for better patient outcomes. Identifying genetic factors and new drug targets to increase fetal hemoglobin levels.
Investigating genetic factors in chronic pain development and biomarker research.
Creating new methods to evaluate red cell function and therapy effectiveness.
Our team working together to advance sickle cell disease research